Drug Delivery Business

The top Dexcom stories of 2025 so far

By

Dexcom Stelo glucose monitor
The Stelo glucose monitor. [Image courtesy of Dexcom]

At Dexcom (Nasdaq:DXCM), one of the leaders in continuous glucose monitoring (CGM), innovation continues to roll on.

The company has been expanding its offerings with next-generation sensors, over-the-counter offerings and improved wear times. It has also introduced new AI features and enhanced connectivity that make diabetes management easier.

Dexcom’s CTO Girish Naganathan will speak about the future of connected health at DeviceTalks West, Oct. 15–16, 2025 in Santa Clara, California. Register at West.DeviceTalks.com.

Dexcom — one of the largest diabetes tech companies in the world — is also featured in MassDevice’s 2025 Diabetes Tech Innovations Special Report. (Read the free report HERE.)

 

Visit MassDevice for the top stories for the company so far this year>>

IN CASE YOU MISSED IT

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].